Daniya Mohammed Sabrah

Dr. Daniya Mohammed Sabrah

University of Louisville, Louisville, Kentucky, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DSDaniya Mohammed Sabrah
Daniya Mohammed Sabrah
NPNaiya Patel
Naiya Patel
Seyed M. KarimiSeyed M. Karimi
Seyed M. Karimi
Bert LittleBert Little
Bert Little
DADemetra Elizabeth Antimisiaris
Demetra Elizabeth Antimisiaris
AAAhmed Alabdrabalnabi
Ahmed Alabdrabalnabi
Background: Hospital readmissions among pediatric sickle cell disease (SCD) patients significantly strain healthcare systems. In Saudi Arabia, limited research has ex-plored the role of bone marrow transplant in reducing recurrent emergency and inpatient readmissions among children with SCD. This study investigates the impact of bone mar-row treatment on post-discharge readmission rates using a multi-episode survival framework. Methods: We conducted a retrospective cohort study using electronic health records from 2015 to 2023 of children aged ≤11 years diagnosed with SCD across multiple hospitals in Saudi Arabia. A multi-episode survival analysis based on the Andersen-Gill model was employed to evaluate the effect of bone marrow transplant on readmission rates up to 30, 90, 180, and 365 days following the first emergency or inpatient discharge. Patients were categorized into treatment (received bone marrow) and control groups, ad-justing for demographic, clinical, and healthcare system-related covariates. Results: The study included 234 patients. Bone marrow transplant significantly reduced the hazard of emergency readmissions within 365 days (HR=0.16; 95% CI: 0.06–0.44), while increasing the hazard of inpatient readmissions (HR=5.56; 95% CI: 3.03–11.11), possibly due to short-term immunosuppression post-transplant. Additional risk factors for higher read-mission rates included greater prior-year emergency visits, SCD related complications, and healthcare facility type. Conclusions: Bone marrow transplant appears effective in reducing emergency readmissions in pediatric SCD patients, though it may increase short-term inpatient admissions. Findings underscore the importance of targeted post-transplant care and inform healthcare policy on effective interventions for reducing readmission burdens in Saudi Arabia.

DSDaniya Mohammed Sabrah
Daniya Mohammed Sabrah
Seyed M. KarimiSeyed M. Karimi
Seyed M. Karimi
Bert LittleBert Little
Bert Little
DADemetra Elizabeth Antimisiaris
Demetra Elizabeth Antimisiaris
DADr. Danyah A Aldailami
Dr. Danyah A Aldailami
FAFatima Aldarweesh
Fatima Aldarweesh
(1) Background: In Saudi Arabia, a high-income country with a publicly funded healthcare system, sickle cell disease (SCD) remains a major pediatric health challenge. This study aimed to identify factors associated with healthcare utilization, specifically inpatient (IP), outpatient (OP), and emergency department (ED) visits, among children with SCD in Saudi Arabia. (2) Methods: A retrospective observational study was conducted using data from the KAIMRC registry (2015-2023), including 450 children under 12 years old diagnosed with SCD. Negative binomial regression models were employed to analyze the annual average visits, accounting for clinical, demographic, and regional healthcare resource variables. (3) Results: Key predictors of IP visits included complication count, crisis episodes, and region (eastern, western, and southern regions had higher utilization than central). ED visits were positively associated with complications, crisis episodes, and hydroxyurea use, but negatively associated with bone marrow transplant receipt. OP visits increased with higher Charlson Comorbidity Index scores, age, and bone marrow transplant, but were lower in the eastern region. (4) Conclusions: These findings highlight the influence of clinical and regional factors even within an equitable, high-resource healthcare system.